These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496 [TBL] [Abstract][Full Text] [Related]
4. Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis. Tolosa L; Gómez-Lechón MJ; Jiménez N; Hervás D; Jover R; Donato MT Toxicol Appl Pharmacol; 2016 Jul; 302():1-9. PubMed ID: 27089845 [TBL] [Abstract][Full Text] [Related]
5. Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro. Cheng Y; Zhang J; Shang J; Zhang L Pharmacology; 2009; 84(3):183-90. PubMed ID: 19752584 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic effects of 100 reference compounds on Hep G2 and HeLa cells and of 60 compounds on ECC-1 and CHO cells. I mechanistic assays on ROS, glutathione depletion and calcein uptake. Schoonen WG; Westerink WM; de Roos JA; Débiton E Toxicol In Vitro; 2005 Jun; 19(4):505-16. PubMed ID: 15826808 [TBL] [Abstract][Full Text] [Related]
7. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development. Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938 [TBL] [Abstract][Full Text] [Related]
8. Aclarubicin-induced ROS generation and collapse of mitochondrial membrane potential in human cancer cell lines. Rogalska A; Koceva-Chyła A; Jóźwiak Z Chem Biol Interact; 2008 Oct; 176(1):58-70. PubMed ID: 18692031 [TBL] [Abstract][Full Text] [Related]
9. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis. van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975 [TBL] [Abstract][Full Text] [Related]
10. Identification of early proteomic markers for hepatic steatosis. Meneses-Lorente G; Watt A; Salim K; Gaskell SJ; Muniappa N; Lawrence J; Guest PC Chem Res Toxicol; 2006 Aug; 19(8):986-98. PubMed ID: 16918237 [TBL] [Abstract][Full Text] [Related]
11. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes. Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751 [TBL] [Abstract][Full Text] [Related]
12. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies. Nioi P; Perry BK; Wang EJ; Gu YZ; Snyder RD Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588 [TBL] [Abstract][Full Text] [Related]
13. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Lan SF; Starly B Toxicol Appl Pharmacol; 2011 Oct; 256(1):62-72. PubMed ID: 21839104 [TBL] [Abstract][Full Text] [Related]
14. Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential. LeCureux L; Cheng CS; Herbst J; Reilly TP; Lehman-McKeeman L; Otieno M Toxicol In Vitro; 2011 Dec; 25(8):1934-43. PubMed ID: 21767630 [TBL] [Abstract][Full Text] [Related]
15. Validation of an in vitro screen for phospholipidosis using a high-content biology platform. Morelli JK; Buehrle M; Pognan F; Barone LR; Fieles W; Ciaccio PJ Cell Biol Toxicol; 2006 Jan; 22(1):15-27. PubMed ID: 16463016 [TBL] [Abstract][Full Text] [Related]
16. Bioassay-guided isolation of neuroprotective compounds from Loranthus parasiticus against H₂O₂-induced oxidative damage in NG108-15 cells. Wong DZ; Kadir HA; Ling SK J Ethnopharmacol; 2012 Jan; 139(1):256-64. PubMed ID: 22107836 [TBL] [Abstract][Full Text] [Related]
17. A cell-based, multiparametric sensor approach characterises drug-induced cytotoxicity in human liver HepG2 cells. Seeland S; Török M; Kettiger H; Treiber A; Hafner M; Huwyler J Toxicol In Vitro; 2013 Apr; 27(3):1109-20. PubMed ID: 23416262 [TBL] [Abstract][Full Text] [Related]